高级检索
当前位置: 首页 > 详情页

NLRP3 rs1539019 is significantly associated with chronic obstructive pulmonary disease in a Chinese Han population: a case-control study

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ 预警期刊

单位: [1]Department of Pulmonary and Critical Care Medicine, Sinopharm Tongmei General Hospital, Datong, China [2]China-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [3]Department of Emergency, Chinese PLA General Hospital-Fourth Medical Center, Beijing, China [4]China-Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases, Clinical Center for Pulmonary Infections, Capital Medical University, Beijing, China
出处:
ISSN:

关键词: COPD Polymorphism NLRP3 rs1539019 Susceptibility

摘要:
- OBJECTIVE: COPD is a complex re-spiratory disease characterized by chronic airway inflammation and the airflow limitations are not ful-ly reversible due to the combination of genetic and environmental factors. Genetic factors such as poly-morphisms, may affect the susceptibility of COPD. In the present study, we examined the association between the polymorphisms of three genes and COPD risk in a Chinese Han population.PATIENTS AND METHODS: A total of 375 COPD patients and 284 control subjects were recruited from November 2018 to June 2021. Data on demo-graphic basic information, smoking status, history of coal dust exposure, and peripheral blood were collected from subjects of two groups. Three poly-morphisms (NLRP3 rs1539019, LAMB1 rs4320486, IL-6 rs1800796) were analyzed. Logistic analysis was used to evaluate the genetic contribution of selected SNPs to COPD susceptibility.RESULTS: The AC genotype of NLRP3 rs1539019 significantly decreased COPD risk compared with CC genotype (adjusted OR = 0.508, 95% CI 0.336-0.767). In the stratification analyses, the AC genotype signifi-cantly decreased the risk of COPD in subjects aged 60 and over (p=0.005; adjusted OR = 0.553; 95% CI 0.366-0.835) with current smoking status (p=0.002; adjusted OR = 0.419; 95% CI 0.240-0.732) when com-pared with AA+CC genotype. Moreover, a significant-ly decreased risk for GOLD III COPD was found in genotype AC of NLRP3 rs1539019 (p=0.006; adjust-ed OR = 0.502; 95% CI 0.306-0.822).CONCLUSIONS: Our present study revealed that the genotype AC of NLRP3 rs1539019 is related to a decreased risk of COPD in a Chinese Han popula-tion, a large-sample, multi-center, multi-ethnic study is needed to further confirm our study.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2025]版:
JCR分区:
出版当年[2020]版:
Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Department of Pulmonary and Critical Care Medicine, Sinopharm Tongmei General Hospital, Datong, China [2]China-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
通讯作者:
通讯机构: [1]Department of Pulmonary and Critical Care Medicine, Sinopharm Tongmei General Hospital, Datong, China [2]China-Japan Friendship Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)